ALLMedicine™ Protein-losing Enteropathy Center

Jan 26th, 2023 - Epidermolysis bullosa with pyloric atresia (EB-PA) is characterized by fragility of the skin and mucous membranes, manifested by blistering with little or no trauma; congenital pyloric atresia; renal and/or ureteral anomalies; and protein-losing e...

Jan 20th, 2023 - SAAG Interpretation The serum ascites albumin gradient (SAAG) is a formula used to assist in determining the etiology of ascites. Also see Medscape’s Ascites Albumin Gradient Calculator. The formula is below. SAAG = serum albumin – ascites albumin...

Jan 20th, 2023 - SAAG Interpretation The serum ascites albumin gradient (SAAG) is a formula used to assist in determining the etiology of ascites. Also see Medscape’s Ascites Albumin Gradient Calculator. The formula is below. SAAG = serum albumin – ascites albumin...

Jan 20th, 2023 - The serum ascites albumin gradient (SAAG) is a formula used to assist in determining the etiology of ascites. Also see Medscape’s Ascites Albumin Gradient Calculator. The formula is below. SAAG = serum albumin – ascites albumin A high gradient (SA...

Jan 19th, 2023 - Fontan operation is a palliative surgical procedure performed in patients with a functional or anatomical single ventricle. After the Fontan procedure, patients face significant risk of morbidity and mortality, and patients with complicated congen...

Jan 19th, 2023 - Fontan operation is a palliative surgical procedure performed in patients with a functional or anatomical single ventricle. After the Fontan procedure, patients face significant risk of morbidity and mortality, and patients with complicated congen...

Jan 17th, 2023 - Disorders of lymphatic function are associated with multiple presentations, the most common of which is lymphedema, a chronic swelling of the extremities, due to impaired lymphatic drainage. It can cause disability and a predisposition to infectio...

Nov 10th, 2022 - The primary objective of the study is to determine the effect of pozelimab on active CD55-deficient protein-losing enteropathy (PLE; CHAPLE). The secondary objectives of the study are: To evaluate the safety and tolerability of pozelimab in patien...

Jul 26th, 2022 - This study is phase 2 open-label, single-arm, multi-center clinical trial to evaluate the efficacy and safety of Camostat mesylate in patients with Protein-losing enteropathy after Fontan operation.

Jan 11th, 2022 - For infants and newborns who have a heart defect at birth that leaves them with one functional ventricle, there is a series of surgeries that are required to allow survival. These surgeries ultimately lead to a common heart and great blood vessel ...

Mar 1st, 2022 - Pembrolizumab (Keytruda) in combination with gemcitabine and concurrent hypofractionated radiotherapy (RT) appears to be a promising and efficacious, bladder-sparing regimen for patients with muscle-invasive bladder cancer (MIBC), according to fin...

Aug 26th, 2019 - Erosive protein-losing enteropathy secondary to disseminated histoplasmosis This patient was treated with amphotericin B and transitioned to oral itraconazole with frequent blood level monitoring to ensure absorption. His symptoms improved gradual.

Aug 26th, 2019 - Erosive protein-losing enteropathy secondary to disseminated histoplasmosis This patient was treated with amphotericin B and transitioned to oral itraconazole with frequent blood level monitoring to ensure absorption. His symptoms improved gradual.

Jul 2nd, 2019 - With improving survival after the Fontan procedure, adult survivors need periodic cardiovascular and end-organ surveillance testing, according to a scientific statement from the American Heart Association (AHA). Globally, the population of adults ...

Jan 2nd, 2019 - Primary intestinal lymphangiectasia Histologic examination shows chronic inflammation of the ileum characterized by increased lymphoplasma cell infiltration of lamina propria without malignancy. Moreover, marked dilatation of lymphatic ducts that.